THE ROLE OF CLINICAL OUTCOME ASSESSMENT DATA IN THE DRUG APPROVAL PROCESS OF PRODUCTS FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY IN THE USA AND EUROPE- A REVIEW OF GUIDANCE DOCUMENTS AND AUTHORIZATIONS OF MEDICINAL PRODUCTS
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1012
https://www.valueinhealthjournal.com/article/S1098-3015(16)01080-9/fulltext
Title :
THE ROLE OF CLINICAL OUTCOME ASSESSMENT DATA IN THE DRUG APPROVAL PROCESS OF PRODUCTS FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY IN THE USA AND EUROPE- A REVIEW OF GUIDANCE DOCUMENTS AND AUTHORIZATIONS OF MEDICINAL PRODUCTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01080-9&doi=10.1016/j.jval.2016.03.1012
First page :
A253
Section Title :
Systemic Disorders/Conditions - Patient-Reported Outcomes & Patient Preference Studies
Open access? :
No
Section Order :
945